← FDA Drug Approvals (Drugs@FDA)

BRIDION

NDA · New Drug Application · Sponsor: MSD SUB MERCK · Approved 2015-12-15

Drug application

FDA Application #

NDA022225

Application type

New Drug Application

Brand name

BRIDION

Generic name

SUGAMMADEX

Active ingredients

SUGAMMADEX SODIUM

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

MSD SUB MERCK

Manufacturer

Merck Sharp & Dohme LLC

First approval

2015-12-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown